| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.63M | — |
| Operating expense | — | — |
| Net income | -21.50M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ACRS returned +256.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +113.0% |
| 1 year | +256.1% |
| 5 years | -60.5% |
| 10 years | -68.2% |
| All-time high | $31.23 (Feb 2017) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ACRS would be worth today ›No. Aclaris Therapeutics, Inc. has not paid a dividend in the past 12 months.
Aclaris Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol ACRS.
Aclaris Therapeutics, Inc. is part of the Healthcare sector.
Aclaris Therapeutics, Inc. has a market cap of 943.54M USD, based on the latest quote.
Aclaris Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
